Literature DB >> 14569725

Seroprevalence of human parvovirus B19 infection in an urban population in Malaysia.

S L Ooi1, P S Hooi, B H Chua, S K Lam, K B Chua.   

Abstract

A seroepidemiological study carried out on 800 stored serum samples collected between January 1999 to December 2000 derived from an urban population in Malaysia showed that the overall seropositive rate of human paravovirus B19 infection was 37.6%, with an overall geometric mean titre (GMT) of 18.3 IU. The seropositive rates of B19 among the male and female populations were 39.0% and 36.3% respectively. The seropositive rates among the racial groups were 37.2%, 38.2%, 38.1% and 29.4% respectively for the Malays, Chinese, Indians and other races. There was no statistical significant gender and racial differences in the B19 seropositive rates. When compared with the seroprevalence of B19 infection in other Asian countries, the seropositive rate of B19 in Malaysia was low in the younger age group and increased steadily with age. The unusual finding in this study was the presence of a high seropositive rate in those between six months to five years of age, especially in children in the one year old age group.

Entities:  

Mesh:

Year:  2002        PMID: 14569725

Source DB:  PubMed          Journal:  Med J Malaysia        ISSN: 0300-5283


  3 in total

1.  SEROPREVALENCE OF ERYTHROVIRUS B19 IgG AMONG SAUDI BLOOD DONORS IN MAKKAH, SAUDI ARABIA.

Authors:  Ayman K Johargy
Journal:  J Family Community Med       Date:  2009-09

Review 2.  Seroprevalence of ToRCH Pathogens in Southeast Asia.

Authors:  Franziska E Fuchs; Maude Pauly; Antony P Black; Judith M Hübschen
Journal:  Microorganisms       Date:  2021-03-11

3.  Persistence of human parvovirus B19 in tissues from adult individuals: a comparison with serostatus and its clinical utility.

Authors:  R Aravindh; Uma Nahar Saikia; Baijayantimala Mishra; Vandana Kumari; Subhabrata Sarkar; Mirnalini Sharma; Radha Kanta Ratho; Kusum Joshi
Journal:  Arch Virol       Date:  2014-04-30       Impact factor: 2.574

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.